Colorectal cancer: new developments after the 2013 ECCO/ESMO congress
نویسندگان
چکیده
In 2013, at the congress of the European CanCer Organization and the European Society for Medical Oncology, colorectal cancer was the subject of various oral presentations and posters. In this article, we have selected the most innovative studies that are likely to change our daily practice.
منابع مشابه
ESMO World Congress on Gastrointestinal Cancer And European Post-Chicago Melanoma/Skin Cancer Meeting.
We present sessions on the latest trials and treatments for colorectal cancer from the ESMO World Congress and report on new developments in diagnostics and therapy presented at the European Post-Chicago Melanoma/Skin Cancer Meeting.
متن کاملESMO World Congress on Gastrointestinal Cancer.
This year's annual ESMO World Congress on Gastrointestinal Cancer paid particular attention to the influence of primary tumor sidedness in colorectal cancer as it affects prognosis and treatment outcomes to meet the growing interest in this theory.
متن کاملReport on the 2013 European Multidisciplinary Cancer Congress—ECC 17, Amsterdam, 27 September–1 October 2013: nursing highlights
The European Cancer Organisation (ECCO) was founded on the ideas of the former Federation of European Cancer Societies (FECS). The ECCO was officially announced at the European Cancer Conference in Barcelona in September 2007, replacing the FECS as a dynamic new entity. Through its members, the ECCO represents the interests of over 50,000 professionals in oncology. The ECCO continues to expand ...
متن کاملRecent Developments in Regorafenib Treatment for Gastrointestinal Cancers: Presentations at the European Society for Medical Oncology (esmo) Congress 2016
The European Society for Medical Oncology (ESMO) Congress was held in Copenhagen, Denmark from 7th–11th October 2016. The use of the promiscuous multikinase inhibitor regorafenib (Stivarga®, BAY 73-4506) in the treatment of cancers of the gastrointestinal (GI) tract was strongly featured at this meeting. Regorafenib targets multiple kinases involved in oncogenesis and angiogenesis, and is US Fo...
متن کامل11th International Congress on Targeted Anticancer Therapies (TAT)
The 11th International Congress on Targeted Anticancer Therapies (TAT) was held in Paris for the second time under the presidency of Professor Jean-Charles Soria, Institut Gustave Roussy, Villejuif, France. The TAT Congress was co-sponsored by the Amsterdam-based NDDO Education Foundation and European Society for Medical Oncology (ESMO). NDDO is the primary organizer of all meetings in the TAT ...
متن کامل